Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-05 11:22:20 ET COGT

Published on 05/05/2026 at 11:22 am EDT

Cogent Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 97.35 million compared to USD 71.99 million a year ago.